Debt Advisory

Services tailored to your needs.

The Debt Advisory Group at Raymond James has a time-tested record of advising our corporate clients in raising debt through privately marketed and negotiated transactions. We customize our approach to each situation and leverage our distinct combination of industry knowledge as well as structuring and capital markets expertise to run an effective process that delivers greater certainty of closing on the best terms available in the market. Further, our deep and extensive relationships with a broad range of financing sources provide our clients with valuable market intelligence and distinct access to large pools of private capital.

Typical Financing Structures

  • Asset based
  • Cash flow
  • Unitranche
  • Second lien
  • Mezzanine
  • Unsecured/notes
  • Nontraditional asset-based financings
  • Bridge financings

Typical Transaction Types

  • Growth capital
  • Refinancings
  • Dividend recapitalizations
  • Acquisition financings
  • Working capital/capital expenditures
  • Project financings
  • Special situation financings

Transaction History

Transaction history may include a transaction completed by a Raymond James & Associates banker while at a former firm.


Behind our mission to deliver powerful results and personalized strategies for each of our clients is our team of dedicated investment banking professionals.

Meet Our Investment Banking Professionals

Industry Insight

To select your areas of interest and begin receiving our insights and other updates, click sign up below.

Recent News

Investment Banking  |  March 31, 2025

Raymond James hires John E. Mack III as co-head of security & safety investment banking sector team

Read more about Raymond James hires John E. Mack III as co-head of security & safety investment banking sector team
Investment Banking  |  March 11, 2025

Raymond James hires two senior IT services investment bankers

Read more about Raymond James hires two senior IT services investment bankers
Investment Banking  |  March 5, 2025

Raymond James hires senior biotechnology research analyst

Read more about Raymond James hires senior biotechnology research analyst